Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
24 participants
OBSERVATIONAL
2007-11-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Novel Human Milk Fortifier in Preterm Infants
NCT01373073
Human Milk in Preterm Infants
NCT05228535
Evaluation of Human Milk Fortifiers in Preterm Infants
NCT02307760
Preterm Infants Fed a Human Milk Fortifier
NCT05551975
Post Discharge Human Milk Fortifier in Preterm Infants
NCT00413985
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Very low birth weight and preterm infants who will likely receive fortification of breast milk with HMF
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* exclusive breast milk feedings with intention to fortify with human milk fortifier
Exclusion Criteria
* history of necrotizing enterocolitis
* significant lung disease at the start of the study
6 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Christiana Care Health Services
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert G. Locke, DO
Role: PRINCIPAL_INVESTIGATOR
Christiana Hospital
Christopher T. Hsu, MD
Role: PRINCIPAL_INVESTIGATOR
Christiana Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Christiana Hospital
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
27127
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.